Linomide, an immunomodulator that inhibits T(h)1 cytokine gene expression

International Immunology

Volumn 8, Issue 10, 1996, Pages 1603-1607

  Arad, Gila ^a   Katzenellenbogen, Mark ^a   Levy, Revital ^a   Slavin, Shimon ^b   Kaempfer, Raymond ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Immunosuppression; Linomide; Superantigen; T(h)1 cytokines

Indexed keywords

MESSENGER RNA; ROQUINIMEX;

ARTICLE; AUTOIMMUNITY; BLOOD; BONE MARROW TRANSPLANTATION; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENTEROTOXINS; GENE EXPRESSION REGULATION; HUMANS; HYDROXYQUINOLINES; INTERFERON TYPE II; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOTOXIN-ALPHA; RNA, MESSENGER; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TH1 CELLS;

EID: 0029823877     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.10.1603     Document Type: Article

References (26)

1. Gonzalo, J. A., Gonzalez-Garcia, A., Kalland, T., Hedlund, G., Martinez, C. and Kroemer, G. 1993. Linomide, a novel immunomodulator that prevents death in four models of septic shock. Eur. J. Immunol. 23:2372.
2. Karussis, D. M., Lehmann, D., Slavin, S., Vourka-Karussis, U., Mizrachi-Koll, R., Ovadia, H., Kalland, T. and Abramsky, O. 1993. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc. Natl Acad. Sci. USA 90:6400.
3. Karussis, D. M., Meiner, Z., Lehmann, D., Gomori, J.-M., Schwarz, A., Linde, A., Gjorstrup, P. and Abramsky, O. 1996. Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a pilot double blind placebo controlled study with monthly MRI evaluation. Neurology, in press.
4. Gross, D. J., Sidi, H., Weiss, L., Kalland, T., Rosenmann, E. and Slavin, S. 1994. Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug. Diabetologia 37:1195.
5. Vukanovic, J., Passaniti, A., Hirata, T., Traystman, R. J., Hartley- Asp, B. and Isaacs, J. T. 1993. Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res. 53:1833.
6. Kalland, T. 1990 Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level. J. Immunol. 144:4472.
7. Vukanovic, J., Hartley-Asp, B. and Isaacs, J. T. 1995. Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers. Prostate 26:235.
8. Vukanovic, J. and Isaacs, J. T. 1995. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res. 55:1499.
9. Vukanovic, J. and Isaacs, J. T. 1995. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide. Cancer Res. 55:3517.
10. Gonzalo, J. A., Gonzalez-Garcia, A., Kalland, T., Hedlund, G., Martinez, C. and Kroemer, G. 1994. Linomide inhibits programmed cell death of peripheral T cells in vivo. Eur. J. Immunol. 24:48.
11. Bengtsson, M., Simonsson, B., Carlsson, K., Nilsson, B., Smedmyr, B., Termander, B., Oberg, G. and Tetterman, T. H. 1992. Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia. Transplantation 53:882.
12. Gerez, L., Madar, L., Arad, G., Sharav, T., Reshef, A., Ketzinel, M., Sayar, D., Silberberg, C. and Kaempfer, R. 1991. Aberrant regulation of interleukin-2 but not of interferon-γ gene expression in Down Syndrome (trisomy 21). Clin. Immunol. Immunopathol. 58:251.
13. Arad, G., Tal, C., Ketzinel, M., Nussinovich, R., Deutsch, E., Schlesinger, M., Gerez, L. and Kaempfer, R. 1995. Transient expression of human IL-2 and IFN-γ genes is regulated by interaction between distinct cell subsets. Cell Immunol. 160:240.
14. Lebendiker, M. A., Tal, C., Sayar, D., Pilo, S., Eilon, A., Banai, Y. and Kaempfer, R. 1987. Superinduction of the human gene encoding immune interferon. EMBO J. 6:585.
15. Ketzinel, M., Efrat, S., Sayar, D., Gerez, L., Tal, C., Deutsch, E. Arad, G. and Kaempfer, R. 1991. Regulation of human interleukin- 2 and interferon-γ gene expression by suppressor T lymphocytes. Scand. J. Immunol. 33:593.
16. Maniatis, T., Fritsch, E. F. and Sambrook, J. 1989. Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Arad, G., Nussinovich, R., Na'amad, M. and Kaempfer, R. 1996. Dual control of human interleukin-2 and interferon-γ gene expression by histamine: activation and suppression. Cell Immunol. 170:149.
18. Kaempfer, R., Gerez, L., Farbstein, H., Madar, L., Hirschman, O., Nussinovich, R. and Shapiro, A. 1996. Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression J. Clin. Oncol. 14:1778.
19. Chomeczynski, P. and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyante-phenol-chloroform extraction. Anal. Biochem. 162:156.
20. Gerez, L., Arad, G., Efrat, S., Ketzinel, M. and Kaempfer, R. 1995. Post-transcriptional regulation of human IL-2 gene expression at processing of precursor transcripts. J. Biol. Chem. 270:15-569.
21. Jarrous, N., Osman, F. and Kaempfer, R. 1996. 2-Aminopurine selectively inhibits splicing of tumor necrosis factor-α mRNA. Mol. Cell. Biol. 16:2814.
22. Herman, A., Kappler, J. W., Marrack, P. and Pullen, A. M. 1991. Superantigens: mechanisms of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745.
23. Mosmann, T. R. and Coffman, R. L. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
24. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M. and O'Garra, A. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
25. Stalhandske, T. and Kalland, T. 1986. Effect of the novel immunomodulator LS2616 on the delayed-type hypersensitivity reaction ot Bordetella pertussis in the rat. Immunopharmacology 11:87.
26. Riesbeck, K., Sigvardsson, M., Leanderson, T. and Forgren, A. 1994. Superinduction of cytokine gene transcription , by ciprofloxacin. J. Immunol. 153:343.